Great start in #soho2024 amazing talk in TP53m AML and MDS by Naval Daver, M.D. from MD Anderson Cancer Center. Big shout out to Jayastu Senapati from his contribution reflected in the data.

For those of you at #SOHO2024, check out our follow-up manuscript from last year's Society of Hematologic Oncology (SOHO) on how we can better incorporate PROs into the hematologic oncology space to measure the tolerability of novel therapies. #lymsm #leusm #mmsm #SOHO24 pubmed.ncbi.nlm.nih.gov/39198102/

Dr Lentzsch addressing an unmet need -HR myeloma Suzanne Lentzsch, MD, PhD Herbert Irving Comprehensive Cancer Center #SOHO2024

Updates from #ASC4FIRST by Jorge Cortes MD at #SOHO2024 👫405 pts with ND #CML 💊Randomized to #asciminib vs SOC TKI 🔹Better MMR at 48 weeks 68% vs 49% (primary endpoint) 🔹Less side effects with asciminib 🔸Longer FU is needed to assess long-term safety & TFR #leusm OncoAlert

Top Influencers of #AMLsm 👉 Chris Hourigan Duke Cancer Society of Hematologic Oncology (SOHO) MD Anderson Cancer Center VJHemOnc hcsm.io/2CPJWM5 via Symplur

Top Influencers of #leusm 👉 MD Anderson Cancer Center Society of Hematologic Oncology (SOHO) Naveen Pemmaraju, MD VJHemOnc G Garcia-Manero hcsm.io/2VzYf0d via Symplur

Have you checked out our content from the inaugural #MPNWorkshopNC?🤔 We spoke to leading experts to hear the latest updates in MPNs!🩸🎥 Click here to watch our exclusive video interviews: 👉 ow.ly/XKa150T8uNF 👈 #MPNsm #HemOnc Atrium Health South Piedmont AHEC

#SOHO2024 | Always a delight to catch up with Charlie Craddock CBE! Yesterday, we heard from Prof. Craddock on how personalized treatments can be used to improve post-transplant outcomes in AML, how to address the psychosocial needs of patients with AML & more! #SOHO24 #AMLsm

September is #BloodCancerAwarenessMonth🩸📣 Check out our NEW Trial In Focus feature: #NUTRIVENTION – #dietary evidence in #cancercare 🔍 🍎 🥑 Urvi Shah Memorial Sloan Kettering Cancer Center 👉 ow.ly/bMWQ50T4PJH #BloodCancerAwarenessMonth #MMsm

👉👉👉Wonderful to attend #SOHO24 #SOHO2024 !! Amazing to see its rapid growth ! Dr Fadi Haddad, MD Prof Naveen Pemmaraju, MD Prof Jorge Cortes MD || Society of Hematologic Oncology (SOHO) #leusm #endcancer

#SOHO2024 Dr. Thomas Kipps delivered a captivating presentation on CLL, emphasizing the potential of BTK inhibitors and their impact on high-risk #CLL 🎯 🔬TP53 aberration stands out as a significant independent factor for patients receiving Ibrutinib 🧪

Turns out there are no drugs approved for R/R #PTCLsm in Antarctica. #SOHO2024

what an incredible moment to meet Krina Patel at young investigator scholar luncheon and discuss few realities of life & hemeOnc fellowship. MD Anderson Cancer Center Society of Hematologic Oncology (SOHO) #SOHO2024

Mamtha Balla,MD, MPH, FACP VJHemOnc Memorial Sloan Kettering Cancer Center Thanks! Mamtha Balla,MD, MPH, FACP

#SOHO2024 | A very interesting interview w/ Stephen Ansell, who shared his thoughts on the role of AutoSCT in #HodgkinLymphoma! #Lymsm #Lymphoma #HemOnc #SOHO24

#SOHO2024 | A fantastic update from @daver_leukemia, who spoke on the management of TP53 #AMLsm and the use of FLT3 inhibitors! #LEUsm #Leukemia #HemOnc #SOHO24 MD Anderson Cancer Center

#SOHO2024 | It's always a pleasure to speak to Valeria! Stay tuned for a progress update on LR-MDS. #MDSsm #MyelodysplasticSyndromes #HemOnc #SOHO24

$KPTI Thank you Thanos Dimopoulos h/t VJHemOnc Society of Hematologic Oncology (SOHO)

In this insightful interview, Chloe James of CHU de Bordeaux summarizes recent advancements in the understanding of platelet dysfunction in myeloproliferative neoplasms.🩸 Watch here: 👉 ow.ly/Rwg050Th6oF 👈 ISTH #BleedingDisorders #MPNsm #HemOnc